Seminars in Respiratory and Critical Care Medicine

LinksSchließen

Referenz

Chemaly RF, Dadwal SS, Bergeron A. et al.
A Phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients.

Clin Infect Dis 2020;
71 (11) 2777-2786

Bibliographische Angaben herunterladen

Aufrufen in: